samedan logo

 
 
spacer
home > news > detailed info
INDUSTRY NEWS AND PRESS RELEASES

ICON Releases Environmental, Social and Governance Report

ICON plc

The report looks to the future of ESG for the new ICON while highlighting advancements made in 2020

 


 

Dublin, Ireland, November 22, 2021ICON plc (NASDAQ: ICLR) announced today the release of its 2020 Environmental, Social and Governance (ESG) Report. With the completion of ICON’s acquisition of PRA Health Sciences, the report presents a unified overview of the ESG advancements of both legacy organisations during 2020 and sets out the commitments, policies, and outlook for the combined company.

The ESG Report is available at: https://www.iconplc.com/about/esg/

“As a combined company, new ICON is focused on continuing to develop its ESG strategy and initiatives,” said ICON CEO Steve Cutler. “This report may be a look back to 2020, but it also demonstrates the great promise of the two organisations joining together to become the healthcare intelligence partner of choice. New ICON will continue to make a positive social and environmental impact and pursue our ESG goals and targets.”

For more information about ICON’s ESG efforts, please visit https://www.iconplc.com/about/esg/

phone +353 1 291 2883
email info-clinical@iconplc.com
web www.iconplc.com
email ICON plc, Headquarters, South County Business Park, Leopardstown, Dublin 18, Ireland
 
Print this page
Send to a friend
   
spacer
News and Press Releases

ENHANC3D GENOMICS Awarded QuickFire Challenge Grant

Cambridge, UK – 26 May 2022: ENHANC3D GENOMICS (“Enhanc3D”), a biotechnology company unlocking the full potential of the human 3D genome to accelerate patient-centric medicine, announces it has been selected as one of the awardees under Johnson & Johnson Innovation’s Immunology Innovations QuickFire Challenge. The Challenge called for innovative companies with transformative potential solutions aiming to advance precision medicine approaches in immune-mediated disease. Enhanc3D will receive grant funding, one year of residency at Johnson & Johnson Innovation – JLABS, and mentorship from experts at the Johnson & Johnson Family of Companies.
More info >>


White Papers

ConsulTech GmbH

ConsulTech GmbH

ConsulTech is a consulting company founded in 1992. Since then, we have been supporting biotech-nology, pharmaceutical and medical technology companies as well as research institutions with the entire process of setting-up and executing proposals for R&D projects. In projects funded by the European Commission, ConsulTech supports the coordinator by resuming administrative tasks allow-ing coordinators and partners to fully concentrate on the scientific and technical success of the pro-ject. We solve financial and administrative issues, organise meetings, take care of the timely delivery of milestones and reports and much more.
More info >>

Industry Events

Connect in Pharma

14-15 September 2022, Plaexpo, Geneva, Switzerland

The new event driving innovation for pharma and biopharma businesses, Connect in Pharma will unite key players in Pharmaceutical and Biopharmaceutical packaging and production in Geneva on 14 – 15 September 2022.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement